EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advances, Mechanisms, and Clinical Perspectives for the In Vitro Maturation of Human Oocytes

Marta Gargallo-Alonso, Helen M Picton, Clara Malo

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms27010005 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Marta Gargallo-Alonso und 2 weiteren Autor:innen. Beteiligte Einrichtung: Tissue Microenvironment (TME) Lab, Aragón Institute of Engineering Research (I3A), University of Zaragoza, 50018 Zaragoza, Spain. Hauptthemen laut MEDLINE: In Vitro Oocyte Maturation Techniques, Oocytes. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The in vitro maturation (IVM) of human oocytes represents a valuable assisted reproductive technology that bypasses the need for full ovarian stimulation, offering safer alternatives for patients with polycystic ovary syndrome (PCOS), resistant ovary syndrome, or those requiring fertility preservation before oncological treatment. Despite its potential, IVM efficiency remains lower than that of conventional in vitro fertilization (IVF) due to incomplete understanding of the molecular and metabolic mechanisms underpinning oocyte maturation. This review summarizes recent advances in IVM, including biphasic or simulated physiological oocyte maturation (SPOM) systems, optimization of culture media through hormones, growth factors, and antioxidants, and the influence of cumulus–oocyte communication on developmental competence. We also discuss the biochemical regulation of meiosis, metabolic interactions, and gene expression patterns associated with oocyte quality. Furthermore, we examine the translational and clinical applications of IVM in human fertility treatment, highlighting its efficacy in PCOS and oncofertility cases, and the limitations that persist in replicating in vivo conditions. Emerging technologies such as microfluidic and three-dimensional culture systems show promise in enhancing oocyte competence and embryo yield. Continued research into the molecular mechanisms governing oocyte maturation will be key to improving IVM outcomes and integrating this approach as a mainstream option in reproductive medicine.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

In Vitro Oocyte Maturation TechniquesOocytesHumansFemalePolycystic Ovary SyndromeCumulus CellsFertilization in Vitro

Stichwörter der Autor:innen

PCOSSPOMassisted reproductionbiphasic IVMcumulus–oocyte complexfertility preservationfolliculogenesisin vitro maturation (IVM)oocyteoocyte competenceoxidative stress

Autor:innen und Institutionen

  • Tissue Microenvironment (TME) Lab, Aragón Institute of Engineering Research (I3A), University of Zaragoza, 50018 Zaragoza, Spain.
  • Institute for Health Research Aragón (IIS Aragón), 50009 Zaragoza, Spain.
  • Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, School of Medicine, University of Leeds, Leeds LS2 9JT, UK.

Zitieren

APA

Gargallo-Alonso, M., Picton, H. M., & Malo, C. (2025). Advances, Mechanisms, and Clinical Perspectives for the In Vitro Maturation of Human Oocytes. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010005

Vancouver

Gargallo-Alonso M, Picton HM, Malo C. Advances, Mechanisms, and Clinical Perspectives for the In Vitro Maturation of Human Oocytes. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms27010005

BibTeX
@article{GargalloAlonso2025,
  author = {Gargallo-Alonso, Marta and Picton, Helen M and Malo, Clara},
  title = {Advances, Mechanisms, and Clinical Perspectives for the In Vitro Maturation of Human Oocytes},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms27010005}
}
Kostenlos starten →